NO20083760L - Nye formuleringer - Google Patents

Nye formuleringer

Info

Publication number
NO20083760L
NO20083760L NO20083760A NO20083760A NO20083760L NO 20083760 L NO20083760 L NO 20083760L NO 20083760 A NO20083760 A NO 20083760A NO 20083760 A NO20083760 A NO 20083760A NO 20083760 L NO20083760 L NO 20083760L
Authority
NO
Norway
Prior art keywords
formulations
new formulations
interdose
fpf
therapy
Prior art date
Application number
NO20083760A
Other languages
English (en)
Inventor
John Cappecchi
James Stefely
Trevor Riley
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083760(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of NO20083760L publication Critical patent/NO20083760L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår nye farmasøytisk aerosol-formuleringer, fremgangsmåter for fremstilling av disse, anvendelse av dem i terapi, doserteinhalatorer som inneholder de nevnte formuleringer, og anvendelse av bioforenlige polymerer for å redusere variasjon av interdose og/eller for å forbedre finpartikkel-fraksjonen (FPF) av de nevnte formuleringer.
NO20083760A 2006-03-22 2008-09-01 Nye formuleringer NO20083760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78463406P 2006-03-22 2006-03-22
PCT/US2007/064462 WO2007109698A2 (en) 2006-03-22 2007-03-21 Novel formulations

Publications (1)

Publication Number Publication Date
NO20083760L true NO20083760L (no) 2008-12-17

Family

ID=38523271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083760A NO20083760L (no) 2006-03-22 2008-09-01 Nye formuleringer

Country Status (18)

Country Link
EP (1) EP2012797A2 (no)
JP (1) JP2009530419A (no)
KR (1) KR20080110854A (no)
CN (1) CN101415428A (no)
AR (1) AR060039A1 (no)
AU (1) AU2007226899A1 (no)
BR (1) BRPI0708798A2 (no)
CA (1) CA2646236A1 (no)
CR (1) CR10261A (no)
EA (1) EA200801854A1 (no)
IL (1) IL193723A0 (no)
MA (1) MA30328B1 (no)
MX (1) MX2008011967A (no)
NO (1) NO20083760L (no)
PE (1) PE20080124A1 (no)
TW (1) TW200803870A (no)
WO (1) WO2007109698A2 (no)
ZA (1) ZA200807682B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578169A1 (en) 2009-02-26 2019-12-11 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
SK287576B6 (sk) * 2000-08-05 2011-03-04 Glaxo Group Limited S-fluórmetylester kyseliny 6alfa, 9alfa-difluór-17alfa-[(2- furanylkarboxyl)oxy]-11beta-hydroxy-16alfa-metyl-3-oxo-androsta- 1,4-dién-17beta-karbotiovej, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty

Also Published As

Publication number Publication date
PE20080124A1 (es) 2008-04-21
EA200801854A1 (ru) 2009-04-28
TW200803870A (en) 2008-01-16
CN101415428A (zh) 2009-04-22
IL193723A0 (en) 2009-08-03
WO2007109698A2 (en) 2007-09-27
MA30328B1 (fr) 2009-04-01
ZA200807682B (en) 2009-11-25
WO2007109698A3 (en) 2008-12-18
KR20080110854A (ko) 2008-12-19
EP2012797A2 (en) 2009-01-14
JP2009530419A (ja) 2009-08-27
CR10261A (es) 2008-11-26
BRPI0708798A2 (pt) 2011-06-14
AR060039A1 (es) 2008-05-21
AU2007226899A1 (en) 2007-09-27
MX2008011967A (es) 2009-01-14
CA2646236A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
PH12018500639A1 (en) Optimized monoclonal antibodies agaist tissue factor pathway inhibitor (tfpi)
MY161088A (en) Agonists of gpr40
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
NO20065936L (no) Sulfonyletylfosfordiamidater for anvendelse ved behandling av cancer.
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
BR112014008609A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, método para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
HK1129376A1 (en) Novel imidazole derivatives, preparation and user thereof as medicine
JO3122B1 (ar) مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
UY33219A (es) Cetoenoles cíclicos para terapias
FR2977494B1 (fr) Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
NO20083760L (no) Nye formuleringer
WO2011113000A8 (en) Novel ester containing compositions and methods
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
GB0615105D0 (en) Novel compounds
MX2009012712A (es) Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application